Meds & supplements › Erenumab
Medicine
Erenumab
AIMOVIG is indicated for the preventive treatment of migraine in adults.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- AIMOVIG is indicated for the preventive treatment of migraine in adults.
- Do not take if
- AIMOVIG is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients.
- Reactions have included anaphylaxis and angioedema.
Side effects, and when to stop
The following serious adverse reactions are described below and elsewhere in the labeling:
- Hypersensitivity Reactions
- Constipation with Serious Complications
- Hypertension
- Raynaud's Phenomenon
Who should not take it
AIMOVIG is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients. Reactions have included anaphylaxis and angioedema.
Storing it
- Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use.
- If removed from the refrigerator, AIMOVIG should be kept at room temperature (up to 25°C [77°F]) in the original carton and must be used within 7 days. Throw away AIMOVIG that has been left at room temperature for more than 7 days.
- Do not freeze.
- Do not shake.
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Erenumab; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/erenumab
- APA 7th
sofidex. (2026, August 2). Erenumab. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/erenumab
- AMA 11th
Erenumab. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/erenumab
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.